Assessing patient satisfaction following treatment with Semaglutide injection for type 2 diabetes mellitus
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000053067
- Lead Sponsor
- Kimitsu Chuo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 103
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who do not agree to participate in the study Patients judged by the attending physician that there is no indication for Semaglutide injection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of Satisfaction score measured in the DTSQ by seven possible responses (varying from 0; very dissatisfied, to 6; very satisfied, varying by integers), both previous and six months subsequent to Semaglutide injection.
- Secondary Outcome Measures
Name Time Method Changes in eating behavior measured by the eating behavior questionnaire and the assessment of the efficacy of the drug before and after six months of semaglutide injection.